Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Macular Degeneration Research
Completed Award

Johanna Seddon, M.D.

Massachusetts Eye & Ear Infirmary
Boston, MA

Title: Biological Factors for Age-Related Macular Degeneration
Non-Technical Title:

Duration: April 1, 2002 - March 31, 2003
Award Type: Standard
Award Amount: $42,362

Details:

The objective of this study is to test whether known biological markers of inflammation are correlated with the progression of age-related macular degeneration (AMD). Dr. Seddon hypothesizes that AMD is mediated, at least in part, by the same factors shown to be related to other age-related diseases, like atherosclerosis. These factors include chronic inflammation, oxidative processes and nutritional factors. Dr. Seddon is examining the levels of three inflammatory markers in serum, C-reactive protein, interleukin-6 and tumor necrosis factor. She will measure the level of these factors in the serum of 474 patients from the Age-Related Eye Disease Study (AREDS), sponsored by the National Eye Institute, and correlate them to the progression of AMD. Identifying circulating risk factors for AMD may constitute a useful means for screening for AMD in a clinical setting. It is also hoped that the identification of modifiable risk factors can lead to improved therapies and a possible prevention of this disease.

::

]]